• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病进展过程中的染色质可及性景观。

The Chromatin Accessibility Landscape of Nonalcoholic Fatty Liver Disease Progression.

机构信息

Department of Biological Sciences, Institute of Molecular Biology & Genetics, Seoul National University, Seoul 08826, Korea.

Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang 37673, Korea.

出版信息

Mol Cells. 2022 May 31;45(5):343-352. doi: 10.14348/molcells.2022.0001.

DOI:10.14348/molcells.2022.0001
PMID:35422452
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9095509/
Abstract

The advent of the assay for transposase-accessible chromatin using sequencing (ATAC-seq) has shown great potential as a leading method for analyzing the genome-wide profiling of chromatin accessibility. A comprehensive reference to the ATAC-seq dataset for disease progression is important for understanding the regulatory specificity caused by genetic or epigenetic changes. In this study, we present a genome-wide chromatin accessibility profile of 44 liver samples spanning the full histological spectrum of nonalcoholic fatty liver disease (NAFLD). We analyzed the ATAC-seq signal enrichment, fragment size distribution, and correlation coefficients according to the histological severity of NAFLD (healthy control vs steatosis vs fibrotic nonalcoholic steatohepatitis), demonstrating the high quality of the dataset. Consequently, 112,303 merged regions (genomic regions containing one or multiple overlapping peak regions) were identified. Additionally, we found differentially accessible regions (DARs) and performed transcription factor binding motif enrichment analysis and motif analysis to determine new biomarker candidates. These data revealed the generegulatory interactions and noncoding factors that can affect NAFLD progression. In summary, our study provides a valuable resource for the human epigenome by applying an advanced approach to facilitate diagnosis and treatment by understanding the non-coding genome of NAFLD.

摘要

利用转座酶可及染色质测序(ATAC-seq)进行检测的出现,为分析染色质可及性的全基因组图谱提供了一种很有前途的方法。全面参考 ATAC-seq 数据集对于疾病进展非常重要,有助于了解由遗传或表观遗传变化引起的调控特异性。在这项研究中,我们对跨越非酒精性脂肪性肝病(NAFLD)全组织学谱的 44 个肝脏样本进行了全基因组染色质可及性图谱分析。我们根据 NAFLD 的组织学严重程度(健康对照 vs 脂肪变性 vs 纤维化非酒精性脂肪性肝炎)分析了 ATAC-seq 信号富集、片段大小分布和相关系数,证明了数据集的高质量。结果确定了 112,303 个合并区域(包含一个或多个重叠峰区域的基因组区域)。此外,我们还发现了可及性差异区域(DAR),并进行了转录因子结合基序富集分析和 motif 分析,以确定新的生物标志物候选物。这些数据揭示了影响 NAFLD 进展的基因调控相互作用和非编码因子。总之,通过应用先进的方法来理解 NAFLD 的非编码基因组,我们的研究为人类表观基因组提供了有价值的资源,有助于通过诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dee/9095509/5bde5d209a48/molce-45-5-343-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dee/9095509/60138090c6c7/molce-45-5-343-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dee/9095509/9240593a73a0/molce-45-5-343-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dee/9095509/28d3f37dfa22/molce-45-5-343-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dee/9095509/5bde5d209a48/molce-45-5-343-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dee/9095509/60138090c6c7/molce-45-5-343-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dee/9095509/9240593a73a0/molce-45-5-343-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dee/9095509/28d3f37dfa22/molce-45-5-343-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dee/9095509/5bde5d209a48/molce-45-5-343-f4.jpg

相似文献

1
The Chromatin Accessibility Landscape of Nonalcoholic Fatty Liver Disease Progression.非酒精性脂肪性肝病进展过程中的染色质可及性景观。
Mol Cells. 2022 May 31;45(5):343-352. doi: 10.14348/molcells.2022.0001.
2
ATAC-STARR-seq reveals transcription factor-bound activators and silencers within chromatin-accessible regions of the human genome.ATAC-STARR-seq 揭示了人类基因组中染色质可及区域内转录因子结合的激活子和沉默子。
Genome Res. 2022 Aug 25;32(8):1529-1541. doi: 10.1101/gr.276766.122.
3
Epigenetic Application of ATAC-Seq Based on Tn5 Transposase Purification Technology.基于 Tn5 转座酶纯化技术的 ATAC-Seq 的表观遗传学应用。
Genet Res (Camb). 2022 Aug 11;2022:8429207. doi: 10.1155/2022/8429207. eCollection 2022.
4
Analytical Approaches for ATAC-seq Data Analysis.ATAC-seq 数据分析的分析方法。
Curr Protoc Hum Genet. 2020 Jun;106(1):e101. doi: 10.1002/cphg.101.
5
Genome-wide analysis of chromatin accessibility using ATAC-seq.使用ATAC-seq进行全基因组染色质可及性分析。
Methods Cell Biol. 2019;151:219-235. doi: 10.1016/bs.mcb.2018.11.002. Epub 2018 Dec 21.
6
Chromatin accessibility profiling by ATAC-seq.染色质可及性分析的 ATAC-seq 技术。
Nat Protoc. 2022 Jun;17(6):1518-1552. doi: 10.1038/s41596-022-00692-9. Epub 2022 Apr 27.
7
An ATAC-seq atlas of chromatin accessibility in mouse tissues.小鼠组织染色质可及性的 ATAC-seq 图谱。
Sci Data. 2019 May 20;6(1):65. doi: 10.1038/s41597-019-0071-0.
8
Assay for Transposase-Accessible Chromatin Using Sequencing (ATAC-seq) Data Analysis.利用测序技术进行转座酶可及染色质分析(ATAC-seq)数据分析
Curr Protoc Hum Genet. 2017 Jan 11;92:20.4.1-20.4.13. doi: 10.1002/cphg.32.
9
Review and Evaluate the Bioinformatics Analysis Strategies of ATAC-seq and CUT&Tag Data.综述和评估 ATAC-seq 和 CUT&Tag 数据的生物信息学分析策略。
Genomics Proteomics Bioinformatics. 2024 Sep 13;22(3). doi: 10.1093/gpbjnl/qzae054.
10
Dissecting the Epigenome Driving Drug Resistance by ATAC-Seq.通过 ATAC-Seq 解析驱动耐药性的表观基因组。
Methods Mol Biol. 2022;2535:171-185. doi: 10.1007/978-1-0716-2513-2_14.

引用本文的文献

1
Multi-omics insights into functional alterations of the liver in growth-retarded offspring: transcriptomic, epigenetic and metabolomic profiles.对生长迟缓后代肝脏功能改变的多组学见解:转录组学、表观遗传学和代谢组学图谱
BMC Genomics. 2025 Aug 5;26(1):724. doi: 10.1186/s12864-025-11896-0.
2
Single-cell eQTL analysis identifies genetic variation underlying metabolic dysfunction-associated steatohepatitis.单细胞eQTL分析确定了代谢功能障碍相关脂肪性肝炎潜在的基因变异。
Nat Genet. 2025 Jun 25. doi: 10.1038/s41588-025-02237-8.
3
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.

本文引用的文献

1
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病成人患者结局的前瞻性研究。
N Engl J Med. 2021 Oct 21;385(17):1559-1569. doi: 10.1056/NEJMoa2029349.
2
Disease-specific eQTL screening reveals an anti-fibrotic effect of AGXT2 in non-alcoholic fatty liver disease.疾病特异性 eQTL 筛选揭示 AGXT2 在非酒精性脂肪性肝病中的抗纤维化作用。
J Hepatol. 2021 Sep;75(3):514-523. doi: 10.1016/j.jhep.2021.04.011. Epub 2021 Apr 20.
3
NEUROD1 Intrinsically Initiates Differentiation of Induced Pluripotent Stem Cells into Neural Progenitor Cells.
亚太肝脏研究协会代谢功能障碍相关脂肪性肝病诊断和管理临床实践指南
Hepatol Int. 2025 Apr;19(2):261-301. doi: 10.1007/s12072-024-10774-3. Epub 2025 Feb 27.
4
Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application.染色质可及性:生物学功能、分子机制及治疗应用
Signal Transduct Target Ther. 2024 Dec 4;9(1):340. doi: 10.1038/s41392-024-02030-9.
5
Sweet pepper extract reduces fat storage in by SREBP-SCD axis based on multiomics analysis.基于多组学分析,甜椒提取物通过SREBP-SCD轴减少脂肪储存。
Food Sci Nutr. 2024 Jun 14;12(9):6284-6297. doi: 10.1002/fsn3.4266. eCollection 2024 Sep.
6
Single-cell multiomics guided mechanistic understanding of Fontan-associated liver disease.单细胞多组学指导对Fontan相关肝病的机制理解
Sci Transl Med. 2024 Apr 24;16(744):eadk6213. doi: 10.1126/scitranslmed.adk6213.
7
Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression.鉴定特征基因集可准确判断代谢相关脂肪性肝病的进展。
Clin Mol Hepatol. 2024 Apr;30(2):247-262. doi: 10.3350/cmh.2023.0449. Epub 2024 Jan 26.
8
Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease.锌指转录因子Egf1促进非酒精性脂肪性肝病。
JHEP Rep. 2023 Mar 9;5(6):100724. doi: 10.1016/j.jhepr.2023.100724. eCollection 2023 Jun.
9
Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?非肥胖或瘦型非酒精性脂肪性肝病不容忽视,但鉴于其风险因素,它是可预防的还是不可避免的呢?
Clin Mol Hepatol. 2023 Apr;29(2):381-383. doi: 10.3350/cmh.2023.0088. Epub 2023 Mar 9.
神经分化因子1(NEUROD1)内在地启动诱导多能干细胞向神经祖细胞的分化。
Mol Cells. 2020 Dec 31;43(12):1011-1022. doi: 10.14348/molcells.2020.0207.
4
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis.非酒精性脂肪性肝病谱中的转录组特征分析揭示了肝脂肪变性和纤维化的基因特征。
Sci Transl Med. 2020 Dec 2;12(572). doi: 10.1126/scitranslmed.aba4448.
5
From genome sequencing to the discovery of potential biomarkers in liver disease.从基因组测序到肝脏疾病潜在生物标志物的发现。
BMB Rep. 2020 Jun;53(6):299-310. doi: 10.5483/BMBRep.2020.53.6.074.
6
Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.上皮组织特异性转录因子 ESE3 在肝细胞癌中的表达及预后意义。
Int J Clin Oncol. 2020 Jul;25(7):1334-1345. doi: 10.1007/s10147-020-01675-0. Epub 2020 Apr 28.
7
Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model.非酒精性脂肪性肝炎(NASH)小鼠模型不同阶段的原发性肝类器官培养的功效
Biomaterials. 2020 Apr;237:119823. doi: 10.1016/j.biomaterials.2020.119823. Epub 2020 Jan 27.
8
The ENCODE Blacklist: Identification of Problematic Regions of the Genome.ENCODE 黑名单:基因组中问题区域的鉴定。
Sci Rep. 2019 Jun 27;9(1):9354. doi: 10.1038/s41598-019-45839-z.
9
Transcriptional regulation of Hepatic Stellate Cell activation in NASH.非酒精性脂肪性肝炎中肝星状细胞激活的转录调控。
Sci Rep. 2019 Feb 20;9(1):2324. doi: 10.1038/s41598-019-39112-6.
10
Triggering and resolution of inflammation in NASH.NASH 中炎症的触发和解决。
Nat Rev Gastroenterol Hepatol. 2018 Jun;15(6):349-364. doi: 10.1038/s41575-018-0009-6.